Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 3:50 AM ET

Sponsor Check › Person

Lawrence Blatt

Named as an officer, director or promoter on SEC Form D filings · CA · Jun 19, 2009 → Nov 7, 2023

3deals (issuers)

$193.6Mreported sold

304investors

8Form D filings

2009–2023years on file

Follow this person Look further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:18 AM ET · SEC enforcement last checked: not yet

The short version

Lawrence Blatt is listed as an executive officer and director on 8 SEC Form D filings by 3 issuers between Jun 2009 and Feb 2025: Aligos Therapeutics, Inc. (South San Francisco, CA — biotechnology — 2020–2025; $105M reported sold to 38 investors), Alveo Technologies Inc. (Alameda, CA — biotechnology — 2018–2021; $47.6M reported sold to 248 investors) and ALIOS BIOPHARMA INC (South San Francisco, CA — pharmaceuticals — 2009–2014; $41M reported sold to 18 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 16 years. Across those companies the filings report $193.6M sold in total.

Listed alongside Jack Nielsen (5 shared filings), Leonid Beigelman (5 shared filings), Peter Hirth (4 shared filings), Campbell Murray (3 shared filings), Julian Symons (3 shared filings) and 29 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Lawrence. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), state securities regulators (AZ, CA, DE, TX, WA) — none found. Not yet searched: SEC enforcement releases.

What this means Nothing turned up where we looked (2 sources). That does not prove there is nothing — it means none was found in those sources on that date.

What the community is saying

Nothing found on Reddit, BiggerPockets or community forums for high-net-worth investors (searched Oct 24, 2026) — search queued; this line updates when it has run.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

Not yet searched

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched.

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.

No SEC search has run yet for this person.

3. Bankruptcies

None found in sources searched

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:18 AM ET.

4. Differences between public sources

Not made for individual people — comparisons cover issuers and sponsor groups

5. Money to insiders

3 of 7 offerings report sales commissions totalling $11,377,334; 0 report finder's fees; 0 report proceeds to related persons.

Offering (latest filing)	Sales commissions	Finder's fees	To insiders	Paid to sell it	Source
Feb 28, 2025 D Aligos Therapeutics, Inc. File 021-539576	$2,700,192	$0	$0	Jefferies LLC no CRD number reported Piper Sandler & Co. no CRD number reported	EDGAR ↗
Nov 7, 2023 D Aligos Therapeutics, Inc. File 021-496669	$5,529,000	$0	$0	PIPER SANDLER & CO. BrokerCheck CRD 665 ↗	EDGAR ↗
Mar 29, 2021 D Alveo Technologies Inc. File 021-393865	$0	$0	$0	None listed on this filing	EDGAR ↗
Jan 16, 2020 D Aligos Therapeutics, Inc. File 021-358226	$0	$0	$0	None listed on this filing	EDGAR ↗
Feb 14, 2018 D Alveo Technologies Inc. File 021-305594	$3,148,142	$0	$0	Maxim Group LLC no CRD number reported	EDGAR ↗
May 19, 2014 D ALIOS BIOPHARMA INC File 021-217630	$0	$0	$0	None listed on this filing	EDGAR ↗
Jan 29, 2010 D/A ALIOS BIOPHARMA INC File 021-96479	$0	$0	$0	None listed on this filing	EDGAR ↗

How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named Lawrence Blatt on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

Aligos Therapeutics, Inc.

South San Francisco, CA · Jan 16, 2020 → Feb 28, 2025 · 3 filings

Feb 28, 2025 · D · $105,003,206 sold of $105,003,206 · 12 investors · min. No minimum reported · role: Executive Officer, Director (President and Chief Executive Officer) EDGAR ↗
Nov 7, 2023 · D · $92,150,000 sold of $92,150,000 · 11 investors · min. No minimum reported · role: Executive Officer, Director (Chief Executive Officer) EDGAR ↗
Jan 16, 2020 · D · $85,000,001 sold of $125,000,167 · 38 investors · min. No minimum reported · role: Executive Officer, Director (Chief Executive Officer) EDGAR ↗

Raised $105M from 38 investors (100% of the $105M target) as of the latest filing. Lawrence is listed as executive officer, director on 3 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Alveo Technologies Inc.

Alameda, CA · Feb 14, 2018 → Mar 29, 2021 · 2 filings

Mar 29, 2021 · D · $15,999,997 sold of $30,077,438 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
Feb 14, 2018 · D · $47,605,531 sold of $47,605,531 · 248 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $47.6M from 248 investors (100% of the $30.1M target) as of the latest filing. Lawrence is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗

Sources

Pharmaceuticals

ALIOS BIOPHARMA INC

South San Francisco, CA · Jun 19, 2009 → May 19, 2014 · 3 filings

May 19, 2014 · D · $41,000,001 sold of $41,000,001 · 14 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Jan 29, 2010 · D/A · $30,241,356 sold of $34,241,356 · 18 investors · min. No minimum reported · role: Executive Officer, Director (President and Chief Executive Officer) EDGAR ↗
Jun 19, 2009 · D/A · $11,041,356 sold of $11,041,356 · 18 investors · min. No minimum reported · role: Executive Officer, Director (President and Chief Executive Officer) EDGAR ↗

Raised $41M from 18 investors (100% of the $41M target) as of the latest filing. Lawrence is listed as executive officer, director on 3 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Lawrence 34

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

Person

Leonid Beigelman

Executive Officer, Director · 5 shared filings (2 issuers)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Jack Nielsen

Director · 5 shared filings (2 issuers) · also on 11 other issuers

Jack Nielsen is on 13 issuers in total — a repeat sponsor. Their page lists every one.

Person

Peter Hirth

Director · 4 shared filings (2 issuers) · also on 6 other issuers

Peter Hirth is on 8 issuers in total — a repeat sponsor. Their page lists every one.

Person

Campbell Murray

Director · 3 shared filings (1 issuer) · also on 13 other issuers

Campbell Murray is on 14 issuers in total — a repeat sponsor. Their page lists every one.

Person

Julian Symons

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Kent Gossett

Director · 2 shared filings (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

James Scopa

Director · 2 shared filings (1 issuer) · also on 6 other issuers

James Scopa is on 7 issuers in total — a repeat sponsor. Their page lists every one.

Person

Robin J. Steele

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Carole Nuechterlein

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Lesley Ann Calhoun

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Bridget Martell

Director · 2 shared filings (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Lucinda Quan

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

John Donovan

Executive Officer · 1 shared filing (1 issuer) · also on 7 other issuers

John Donovan is on 8 issuers in total — a repeat sponsor. Their page lists every one.

Person

Heather Preston

Director · 1 shared filing (1 issuer) · also on 4 other issuers

Heather Preston is on 5 issuers in total — a repeat sponsor. Their page lists every one.

Person

Nicholas Brathwaite

Director · 1 shared filing (1 issuer) · also on 16 other issuers

Nicholas Brathwaite is on 17 issuers in total — a repeat sponsor. Their page lists every one.

Person

Isaac Blech

Director · 1 shared filing (1 issuer) · also on 19 other issuers

Isaac Blech is on 20 issuers in total — a repeat sponsor. Their page lists every one.

Person

Peter Moldt

Director · 1 shared filing (1 issuer) · also on 10 other issuers

Peter Moldt is on 11 issuers in total — a repeat sponsor. Their page lists every one.

Person

K. Peter Hirth

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Tom Woiwode

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Jens Eckstein

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Kathleen Sereda Glaub

Director · 1 shared filing (1 issuer) · also on 4 other issuers

Kathleen Sereda Glaub is on 5 issuers in total — a repeat sponsor. Their page lists every one.

Person

Michael Aicher

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Ron Chiarello

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Michael Yi

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Carole Neuchterlein

Director · 1 shared filing (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Sushmita Chanda

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Brian Dowd

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

John Fry

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Margarita Chavez

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Ronald Chiarello

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Julianne Averill

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Yuh-Min Chiang

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Matthew McClure

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Person

Hardean Achneck

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Lawrence Blatt. Their page shows their other deals.

Registrations and other filings

Adviser registration (Form ADV)

Not yet searched. Sources to be searched: SEC Investment Adviser Information Reports — Form ADV data for SEC-registered advisers and exempt reporting advisers (file dated 2026-10-02); SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.

Other offering types (Regulation A and Regulation Crowdfunding)

None found in sources searched.

Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (South San Francisco, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Lawrence Blatt appears on a new Form D, or when a court case or SEC action is matched to them. See plans →

Lawrence Blatt

The short version

What the community is saying

Key records

1. Lawsuits

2. Regulatory actions

3. Bankruptcies

4. Differences between public sources

5. Money to insiders

Deals 3

People around Lawrence 34

Registrations and other filings

Adviser registration (Form ADV)

Other offering types (Regulation A and Regulation Crowdfunding)

Look further

Social and web

Courts

Securities regulators

Business registries

Change history

Request a correction

Add a response

Monitor this person